Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
and potentially other antidiabetic medication
DMU2139 shows 88 and 133-fold selectivity for CYP1B1 over CYP1A1 and CYP1A2
A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene
3R)-1-(acetyloxy)-4-methyl-3-[(2S
Tamibarotene - CAS# 94497-51-5 Catalog No.:M10640-10 and potentially other antidiabetic medicationTamibarotene, also known as SY 1425, is an orally active, synthetic retinoid, developed to overcome all trans retinoic acid (ATRA) resistance, with potential antineoplastic activity. As a specific retinoic acid receptor (RAR) alpha beta agonist, tamibarotene is approximately ten times more potent than ATRA in inducing cell differentiation and apoptosis in HL 60 (human promyelocytic leukemia) cell lines in vitro. Due to a lower affinity for cellular
US$ 126.47
US$ 822.08
US$ 285.79
US$ 188.38
US$ 141.26
US$ 319.63
US$ 475.20
US$ 138.60
US$ 126.47
US$ 273.69
US$ 126.47
US$ 137.54
US$ 126.47
US$ 188.90
US$ 315.33
US$ 117.30
US$ 414.10
US$ 147.58
US$ 328.83
US$ 221.80